These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29056859)

  • 1. Efficacy and Safety of Transdermal Buprenorphine versus Oral Tramadol/Acetaminophen in Patients with Persistent Postoperative Pain after Spinal Surgery.
    Lee JH; Kim JH; Kim JH; Kim HS; Min WK; Park YS; Lee KY; Lee JH
    Pain Res Manag; 2017; 2017():2071494. PubMed ID: 29056859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: a 12-week, randomized, open-label, controlled, parallel-group noninferiority study.
    Karlsson M; Berggren AC
    Clin Ther; 2009 Mar; 31(3):503-13. PubMed ID: 19393841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
    Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
    Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and Safety of Transdermal Buprenorphine Versus Sustained-release Tramadol in Patients With Moderate to Severe Musculoskeletal Pain: An 8-Week, Randomized, Double-Blind, Double-Dummy, Multicenter, Active-controlled, Noninferiority Study.
    Leng X; Li Z; Lv H; Zheng Y; Liu Y; Dai K; Yao C; Yan X; Zeng X
    Clin J Pain; 2015 Jul; 31(7):612-20. PubMed ID: 25503600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized study to compare the efficacy and safety of extended-release and immediate-release tramadol HCl/acetaminophen in patients with acute pain following total knee replacement.
    Park YB; Ha CW; Cho SD; Lee MC; Lee JH; Seo SS; Kang SB; Kyung HS; Choi CH; Chang N; Rhim HY; Bin SI
    Curr Med Res Opin; 2015 Jan; 31(1):75-84. PubMed ID: 25299350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of the seven-day buprenorphine transdermal system in opioid-naïve patients with moderate to severe chronic low back pain: an enriched, randomized, double-blind, placebo-controlled study.
    Steiner DJ; Sitar S; Wen W; Sawyerr G; Munera C; Ripa SR; Landau C
    J Pain Symptom Manage; 2011 Dec; 42(6):903-17. PubMed ID: 21945130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of the efficacy of transdermal buprenorphine patches and prolonged-release tramadol tablets for postoperative pain control after spinal fusion surgery: a prospective, randomized controlled non-inferiority trial.
    Kim HJ; Ahn HS; Nam Y; Chang BS; Lee CK; Yeom JS
    Eur Spine J; 2017 Nov; 26(11):2961-2968. PubMed ID: 28730328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Satisfaction, Adherence and Health-Related Quality of Life with Transdermal Buprenorphine Compared with Oral Opioid Medications in the Usual Care of Osteoarthritis Pain.
    Conaghan PG; Serpell M; McSkimming P; Junor R; Dickerson S
    Patient; 2016 Aug; 9(4):359-71. PubMed ID: 27314487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 2-week, multicenter, randomized, double-blind, double-dummy, add-on study of the effects of titration on tolerability of tramadol/acetaminophen combination tablet in Korean adults with knee osteoarthritis pain.
    Choi CB; Song JS; Kang YM; Suh CH; Lee J; Choe JY; Lee CK; Shim SC; Chung WT; Song GG; Kim HA; Ji JD; Nam EJ; Park SH; Hong YH; Sheen DH; Lim MK; Seo YI; Sung YK; Kim TH; Lee JT; Bae SC
    Clin Ther; 2007 Jul; 29(7):1381-9. PubMed ID: 17825689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buprenorphine transdermal system and quality of life in opioid-experienced patients with chronic low back pain.
    Miller K; Yarlas A; Wen W; Dain B; Lynch SY; Brennan MJ; Ripa SR
    Expert Opin Pharmacother; 2013 Feb; 14(3):269-77. PubMed ID: 23374027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of 4 years of clinical experience with transdermal buprenorphine (Transtec) in post-traumatic pain.
    Correa-Illanes G; Roa RG; B Piñeros JL; Ferrer FT; Adriasola VR
    Pain Manag; 2014 May; 4(3):181-90. PubMed ID: 24835268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine transdermal system for opioid therapy in patients with chronic low back pain.
    Gordon A; Rashiq S; Moulin DE; Clark AJ; Beaulieu AD; Eisenhoffer J; Piraino PS; Quigley P; Harsanyi Z; Darke AC
    Pain Res Manag; 2010; 15(3):169-78. PubMed ID: 20577660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of the extended-release tramadol hydrochloride/acetaminophen fixed-dose combination tablet for the treatment of chronic low back pain.
    Lee JH; Lee CS;
    Clin Ther; 2013 Nov; 35(11):1830-40. PubMed ID: 24183364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, placebo-controlled study of the impact of the 7-day buprenorphine transdermal system on health-related quality of life in opioid-naïve patients with moderate-to-severe chronic low back pain.
    Yarlas A; Miller K; Wen W; Dain B; Lynch SY; Pergolizzi JV; Raffa RB; Ripa SR
    J Pain; 2013 Jan; 14(1):14-23. PubMed ID: 23200931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of transdermal fentanyl in the control of postoperative pain after photorefractive keratectomy.
    Lee YW; Kim YJ; Kim JM; Bae JH; Choi CY
    J Ocul Pharmacol Ther; 2014 Nov; 30(9):783-9. PubMed ID: 25029377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overall safety profile and effectiveness of tramadol hydrochloride/acetaminophen in patients with chronic noncancer pain in Japanese real-world practice.
    Yoshizawa K; Kawai K; Fujie M; Suzuki J; Ogawa Y; Yajima T; Yokomori J
    Curr Med Res Opin; 2015 Nov; 31(11):2119-29. PubMed ID: 26359328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine Transdermal System Improves Sleep Quality and Reduces Sleep Disturbance in Patients with Moderate-to-Severe Chronic Low Back Pain: Results from Two Randomized Controlled Trials.
    Yarlas A; Miller K; Wen W; Lynch SY; Ripa SR; Pergolizzi JV; Raffa RB
    Pain Pract; 2016 Mar; 16(3):345-58. PubMed ID: 25599968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, 14-day, double-blind study evaluating conversion from hydrocodone/acetaminophen (Vicodin) to buprenorphine transdermal system 10 μg/h or 20 μg/h in patients with osteoarthritis pain.
    Ripa SR; McCarberg BH; Munera C; Wen W; Landau CJ
    Expert Opin Pharmacother; 2012 Jun; 13(9):1229-41. PubMed ID: 22409388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery.
    Wininger SJ; Miller H; Minkowitz HS; Royal MA; Ang RY; Breitmeyer JB; Singla NK
    Clin Ther; 2010 Dec; 32(14):2348-69. PubMed ID: 21353105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic impact of buprenorphine transdermal patch in total hip arthroplasty: A randomized controlled trial protocol.
    Li WM; Li FD; Xu H; Sun LC
    Medicine (Baltimore); 2020 Jun; 99(24):e20405. PubMed ID: 32541462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.